Literature DB >> 35149852

Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration.

Fan Yin1, Miao-Miao Wu1, Xiao-Li Wei2, Rui-Xue Ren2, Meng-Hua Liu1,3, Chong-Qing Chen1,3, Liu Yang1,3, Rui-Qian Xie1,3, Shan-Yue Jiang1,3, Xue-Fu Wang4,5, Hua Wang6,7.   

Abstract

Nuclear receptor corepressor 1 (NCoR1) is a corepressor of the epigenetic regulation of gene transcription that has important functions in metabolism and inflammation, but little is known about its role in alcohol-associated liver disease (ALD). In this study, we developed mice with hepatocyte-specific NCoR1 knockout (NCoR1Hep-/-) using the albumin-Cre/LoxP system and investigated the role of NCoR1 in the pathogenesis of ALD and the underlying mechanisms. The traditional alcohol feeding model and NIAAA model of ALD were both established in wild-type and NCoR1Hep-/- mice. We showed that after ALD was established, NCoR1Hep-/- mice had worse liver injury but less steatosis than wild-type mice. We demonstrated that hepatocyte-specific loss of NCoR1 attenuated liver steatosis by promoting fatty acid oxidation by upregulating BMAL1 (a circadian clock component that has been reported to promote peroxisome proliferator activated receptor alpha (PPARα)-mediated fatty β-oxidation by upregulating de novo lipid synthesis). On the other hand, hepatocyte-specific loss of NCoR1 exacerbated alcohol-induced liver inflammation and oxidative stress by recruiting monocyte-derived macrophages via C-C motif chemokine ligand 2 (CCL2). In the mouse hepatocyte line AML12, NCoR1 knockdown significantly increased ethanol-induced CCL2 release. These results suggest that hepatocyte NCoR1 plays distinct roles in controlling liver inflammation and steatosis, which provides new insights into the development of treatments for steatohepatitis induced by chronic alcohol consumption.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  BMAL1; CCL2; NCoR1; alcohol-associated liver disease; monocyte-derived macrophage

Mesh:

Substances:

Year:  2022        PMID: 35149852      PMCID: PMC9433401          DOI: 10.1038/s41401-022-00863-0

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  34 in total

Review 1.  Liver transplantation for alcoholic hepatitis.

Authors:  Gene Y Im; Andrew M Cameron; Michael R Lucey
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

2.  Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice.

Authors:  Meng Wang; Qiang You; Kenton Lor; Fangfang Chen; Bin Gao; Cynthia Ju
Journal:  J Leukoc Biol       Date:  2014-07-16       Impact factor: 4.962

3.  Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.

Authors:  Teresa Ramirez; Yong-Mei Li; Shi Yin; Ming-Jiang Xu; Dechun Feng; Zhou Zhou; Mengwei Zang; Partha Mukhopadhyay; Zoltan V Varga; Pal Pacher; Bin Gao; Hua Wang
Journal:  J Hepatol       Date:  2016-11-18       Impact factor: 25.083

4.  The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene.

Authors:  Lei Yin; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2005-03-10

5.  Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.

Authors:  Aditya Ambade; Patrick Lowe; Karen Kodys; Donna Catalano; Benedek Gyongyosi; Yeonhee Cho; Arvin Iracheta-Vellve; Adeyinka Adejumo; Banishree Saha; Charles Calenda; Jeeval Mehta; Eric Lefebvre; Pamela Vig; Gyongyi Szabo
Journal:  Hepatology       Date:  2019-02-12       Impact factor: 17.425

6.  Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.

Authors:  Xiaodong Ge; Tung-Ming Leung; Elena Arriazu; Yongke Lu; Raquel Urtasun; Brian Christensen; Maria Isabel Fiel; Satoshi Mochida; Esben S Sørensen; Natalia Nieto
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

7.  c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.

Authors:  Sabine Wolter; Anneke Doerrie; Axel Weber; Heike Schneider; Elke Hoffmann; Juliane von der Ohe; Latifa Bakiri; Erwin F Wagner; Klaus Resch; Michael Kracht
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

8.  The isolation and characterization of murine macrophages.

Authors:  Xia Zhang; Ricardo Goncalves; David M Mosser
Journal:  Curr Protoc Immunol       Date:  2008-11

9.  Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.

Authors:  Zhe Chen; Dawei Huo; Lei Li; Zhilong Liu; Zhigang Li; Shuangnian Xu; Yongxiu Huang; Weiru Wu; Chengfang Zhou; Yuanyuan Liu; Mei Kuang; Feng Wu; Hui Li; Pengxu Qian; Guanbin Song; Xudong Wu; Jieping Chen; Yu Hou
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

10.  Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation.

Authors:  Jay Luther; Sanjoy Khan; Manish K Gala; Dmitriy Kedrin; Gautham Sridharan; Russell P Goodman; John J Garber; Ricard Masia; Erik Diagacomo; Daniel Adams; Kevin R King; Samuel Piaker; Hans-Christian Reinecker; Martin L Yarmush; Josepmaria Argemi; Ramon Bataller; Jules L Dienstag; Raymond T Chung; Suraj J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

View more
  1 in total

1.  Editorial: Chronic Liver Disease: New Targets and New Mechanisms.

Authors:  Yanting Ye; Hua Wang; Jinhang Gao; Enis Kostallari
Journal:  Front Mol Biosci       Date:  2022-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.